Literature DB >> 7137164

Human macrophage hemoglobin-iron metabolism in vitro.

G Custer, S Balcerzak, J Rinehart.   

Abstract

An entirely in vitro technique was employed to characterize hemoglobin-iron metabolism by human macrophages obtained by culture of blood monocytes and pulmonary alveolar macrophages. Macrophages phagocytized about three times as many erythrocytes as monocytes and six times as many erythrocytes as pulmonary alveolar macrophages. The rate of subsequent release of 59Fe to the extracellular transferrin pool was two- to fourfold greater for macrophages as compared to the other two cell types. The kinetics of 59Fe-transferrin release were characterized by a relatively rapid early phase (hours 1-4) followed by a slow phase (hours 4-72) for all three cell types. Intracellular movement of iron was characterized by a rapid shift from hemoglobin to ferritin that was complete with the onset of the slow phase of extracellular release. A transient increase in 59Fe associated with an intracellular protein eluting with transferrin was also observed within 1 hour after phagocytosis. The process of hemoglobin-iron release to extracellular transferrin was inhibited at 4 degrees C but was unaffected by inhibitory of protein synthesis, glycolysis, microtubule function, and microfilament function. These data emphasize the rapidity of macrophage hemoglobin iron metabolism, provide a model for characterization of this process in vitro, and in general confirm data obtained utilizing in vivo animal models.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137164     DOI: 10.1002/ajh.2830130105

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

Review 1.  Iron metabolism in the lower respiratory tract.

Authors:  F Mateos; J H Brock; J L Pérez-Arellano
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

2.  Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin.

Authors:  Mitchell D Knutson; Mohamed Oukka; Lindsey M Koss; Fikret Aydemir; Marianne Wessling-Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

Review 3.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

4.  Lysosomotropic agents ameliorate macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: a role for lipid peroxidation.

Authors:  M J Raley; M G Schwacha; D J Loegering
Journal:  Inflammation       Date:  1997-12       Impact factor: 4.092

Review 5.  Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.

Authors:  Biplab K Saha; Woon H Chong; Nils T Milman
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 3.650

6.  Modulators of macrophage transferrin or transferrin-like protein.

Authors:  F I Haurani; T J Quinn
Journal:  Mol Cell Biochem       Date:  1990-06-01       Impact factor: 3.396

7.  [Blood destruction in pulmonary alveoli: signs of vitality and determination of survival time].

Authors:  M Oehmichen
Journal:  Z Rechtsmed       Date:  1984

8.  Perls' Prussian Blue Stains of Lung Tissue, Bronchoalveolar Lavage, and Sputum.

Authors:  Andrew J Ghio; Victor L Roggli
Journal:  J Environ Pathol Toxicol Oncol       Date:  2021       Impact factor: 3.567

9.  Recurrent idiopathic pulmonary hemosiderosis after long-term remission presented with Sjogren's syndrome: Idiopathic no more?

Authors:  Toyoshi Yanagihara; Yuzo Yamamoto; Naoki Hamada; Kunihiro Suzuki; Saiko Ogata-Suetsugu; Eiji Harada; Tetsuzo Tagawa; Minako Fujiwara; Mikiko Hashisako; Junya Fukuoka; Yoichi Nakanishi
Journal:  Respir Med Case Rep       Date:  2018-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.